Stay updated on Pembrolizumab in Esophagogastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Esophagogastric Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.4 is now shown on the page, replacing v3.5.3. This indicates a minor update to the page revision history and does not modify study details or user-facing content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page footer “Revision” value was updated from v3.5.2 to v3.5.3, reflecting a change in the website’s release/version without altering the underlying clinical study information.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded revision v3.5.2 and removed revision v3.5.0.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded Carcinoma of esophagus as a condition term. Added a Resources link to the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check59 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 as part of the site's versioning updates.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.4.3 was added in the revision history and Revision: v3.4.2 was removed. No impact on the study’s data or page usability.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Esophagogastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.